Blog Posts

Sat, Mar 28, 2026

Oil jumped from $70 to $100 on the Iran conflict. Here's how it kills rate cut hopes and which energy stocks I'm buying instead.

Thu, Mar 26, 2026

Honest comparison of 4 stock analysis tools. What's worth paying for and what's not. Real user experience, real pricing, no fluff.

Tue, Mar 24, 2026

Why small-cap oil producers move 10x more than Exxon when crude spikes. Real numbers from the $103 oil rally.

Sun, Mar 22, 2026

I tested 6 AI stock analysis tools. Most are ChatGPT wrappers. Here's what actually works for finding 10x stocks.

Sat, Mar 21, 2026

Rocket Lab launches its first dedicated ESA mission deploying Europe's Celeste LEO navigation satellites. What it means for $RKLB investors.

Fri, Mar 6, 2026

Forget consumer neobanks. I’m looking at the B2B infrastructure plays positioned for a 2026 rerating. Here is my data-driven shortlist.

Thu, Mar 5, 2026

$TTD crashed 76% from highs. Trading at $30 with a $59 analyst consensus. Here's why I think it doubles.

Thu, Mar 5, 2026

I found 3 cybersecurity stocks positioned for a major shift as new federal mandates and AI data risks converge this March.

Tue, Mar 3, 2026

I’m tracking three Aerospace & Defense stocks positioned for a rerating as the FY2026 budget hits the tape. Here is my data-driven plan.

Mon, Mar 2, 2026

My data-driven deep dive into the three nuclear energy stocks I'm watching for a 2026 breakout. No hype, just the numbers.

Tue, Feb 17, 2026

A look at my research process for finding asymmetric nuclear stocks before the March 2026 CERAWeek catalyst. No hype, just data.

Tue, Feb 17, 2026

AI fears are crushing old economy stocks. But the rotation is creating real opportunities. 3 stocks I'm watching right now.

Sun, Feb 15, 2026

Companies report "adjusted" profits while losing money on paper. Here's what Adjusted EBITDA actually hides.

Thu, Feb 5, 2026

I’m moving away from speculative biotech and focusing on these three oncology stocks with real revenue and upcoming 2026 catalysts.

Thu, Jan 15, 2026

Is UUUU a 10x opportunity or a trap? We analyze the US rare earth monopoly, 2026 catalysts, and critical risks before you invest.

Tue, Dec 23, 2025

Is ONON the next Lululemon? We analyze the 65% margins, the "LightSpray" catalyst, and the critical inventory red flag to watch in 2026.

Fri, Dec 19, 2025

A personal walk-through of how I’m researching clean energy stocks going into 2026… quietly.

Wed, Dec 17, 2025

Everyone is chasing AI hype. I’m looking at the 2026 regulatory deadline. Here are the 3 stocks positioned to profit from mandatory compliance.

Wed, Dec 17, 2025

Big Pharma faces a $200B revenue hole in 2026. Here are the 3 cash-rich, commercial-stage stocks I'm tracking to play the coming M&A wave.

Thu, Dec 11, 2025

Oracle dropped 12% on earnings despite a massive backlog. Here is the forensic audit of the $523B RPO, the negative cash flow, and why this setup screams 10x potential.

Fri, Dec 5, 2025

Everyone is watching the cloud. I'm watching the devices that run it. Here are 3 hardware stocks positioned for a major rotation in December 2025.

Thu, Dec 4, 2025

The DOE just signaled a shift in nuclear energy. Here are the 3 stocks I'm tracking for December 2025, from miners to tech disruptors.

Mon, Dec 1, 2025

Credo (CRDO) just reported 272% YoY revenue growth and raised guidance massively. Here’s the forensic audit of the numbers you need to know.

Wed, Nov 26, 2025

Meta won its legal war, ads are booming.. But Zuck is spending $72B a year on AI. Here is why the math says this is a strong buy.

Tue, Nov 25, 2025

The Artemis II launch is approaching. Here are the 3 commercial space stocks I'm analyzing for a potential 2026 breakout, focusing on data over hype.